By bnm Tehran bureau Iranian pharmaceutical company Cobel Darou has launched the GLP-1 receptor agonist semaglutide on the ...
Anyone with Type 2 diabetes will tell you self-injection pens are nothing new, but with the rise of GLP-1 drugs in recent ...